The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.13971 ↗At a glance
Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, 2024. Written by Yuqing Sun and 2 co-authors. Institution: New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, Pharmaceutical Animal Experimental Center, State Key Laborato…. Major MEDLINE topics: Peroxisome Proliferator-Activated Receptors, Liver Diseases. Cited 27 times so far (Crossref); 84 references. Funded by: National Natural Science Foundation of China, Double First-Class University Plan, Natural Science Foundation of Jiangsu Province.
Abstract (original language)
Bile acids are synthesized from cholesterol in the liver. Dysregulation of bile acid homeostasis, characterized by excessive accumulation in the liver, gallbladder and blood, can lead to hepatocellular damage and the development of cholestatic liver disease. Nuclear receptors play a crucial role in the control of bile acid metabolism by efficiently regulating bile acid synthesis and transport in the liver. Among these receptors, peroxisome proliferator‐activated receptor (PPAR), a ligand‐activated transcription factor belonging to the nuclear hormone receptor superfamily, controls the expression of genes involved in adipogenesis, lipid metabolism, inflammation and glucose homeostasis and has emerged as a potential therapeutic target for the treatment of the metabolic syndrome in the past two decades. Emerging evidence suggests that PPAR activation holds promise as a therapeutic target for cholestatic liver disease, as it affects both bile acid production and transport. This review provides a comprehensive overview of recent advances in elucidating the role of PPAR in the regulation of bile acid metabolism, highlighting the current position of PPAR agonists in the treatment of primary biliary cholangitis. By summarizing the specific regulatory effects of PPAR on bile acids, this review contributes to the exploration of novel therapeutic strategies for cholestatic liver diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, Pharmaceutical Animal Experimental Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Chi…
- Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, China.
- Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.
ORCID profiles: Zhenzhou Jiang
Funding
- National Natural Science Foundation of China
- Double First-Class University Plan
- Natural Science Foundation of Jiangsu Province
- Double First Class University Plan
Cite
APA
Sun, Y., Zhang, L., & Jiang, Z. (2024). The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13971
Vancouver
Sun Y, Zhang L, Jiang Z. The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.13971
BibTeX
@article{Sun2024,
author = {Sun, Yuqing and Zhang, Luyong and Jiang, Zhenzhou},
title = {The role of peroxisome proliferator‐activated receptors in the regulation of bile acid metabolism},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.13971}
}
EUVIMED